3B/BMC Files Challenge to Invalidate ResMed (RMD) Patents

3B/BMC Files Challenge to Invalidate ResMed (RMD) Patents
3B Medical, Inc. and BMC Medical Co., Ltd ("3B/BMC") announce the filing of an Inter
Partes Review (IPR) in the United States Patent and Trademark Office challenging the validity of
a ResMed (RMD) patent. The patent challenged under IPR 2014-01196 focuses on a CPAP
humidifier structure. "This IPR filing is probably the first of many IPR challenges to ResMed's
patent portfolio", said James Xu, President of BMC. Since the America Invents Act created the
IPR proceeding in September 2012, hundreds of petitions have been filed challenging patents.
The PTAB has instituted IPR proceedings in most instances and cancelled a majority of patent
claims challenged in these proceedings.
About 3B/BMC:
3B/BMC is a global leader in the development, manufacturing and marketing of medical
products for the treatment and management of sleep disordered breathing.
Contacts: For News Media
Rebecca Velazquez
3B Medical, Inc.
21301 Hwy 27 N
Lake Wales, FL 33859
Email: [email protected]
Tel: (863) 226-6285 ext. 108